Skip to main content
. 2021 Feb 20;13(4):884. doi: 10.3390/cancers13040884

Table 2.

Potential applicability of TARC in non-oncological diseases.

Disease Applicability Ref 1
Atopic dermatitis Diagnostic marker, response marker, severity marker [34,69]
Asthma Diagnostic marker, severity marker, marker for exacerbation [33,70]
Drug eruption Severity marker [71]
Chronic rhinitis Characterize disease phenotype [72]
IgG4-related disease Role in pathogenesis [73]
Alopecia areata Disease activity and response marker [74]
Generalized pustular psoriasis Therapeutic response marker [75]
Chronic obstructive pulmonary disease Marker for decrease lung function [76,77]
Ankylosing spondylitis Role in pathogenesis [78]
Acute eosinophilic pneumonia Diagnostic marker [79]
Bullous pemphigoid Role in pathogenesis [80]
Food protein-induced enterocolitis syndrome Diagnostic marker [81]
Bronchopulmonary Aspergillosis in cystic fibrosis Diagnostic marker [82]
Cutaneous lupus erythematosus Role in pathogenesis [83]
Systemic lupus erythematosus Role in pathogenesis [35]

1 Ref: Reference.